BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20017941)

  • 1. A taxonomy of epithelial human cancer and their metastases.
    Gevaert O; Daemen A; De Moor B; Libbrecht L
    BMC Med Genomics; 2009 Dec; 2():69. PubMed ID: 20017941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique gene expression profile based on pathologic response in epithelial ovarian cancer.
    Spentzos D; Levine DA; Kolia S; Otu H; Boyd J; Libermann TA; Cannistra SA
    J Clin Oncol; 2005 Nov; 23(31):7911-8. PubMed ID: 16204010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm.
    Amin MB; Gupta R; Ondrej H; McKenney JK; Michal M; Young AN; Paner GP; Junker K; Epstein JI
    Am J Surg Pathol; 2009 Mar; 33(3):393-400. PubMed ID: 19047894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
    Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes with bimodal expression are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival.
    Kernagis DN; Hall AH; Datto MB
    J Mol Diagn; 2012; 14(3):214-22. PubMed ID: 22490445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
    Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
    J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma.
    Makretsov NA; Huntsman DG; Nielsen TO; Yorida E; Peacock M; Cheang MC; Dunn SE; Hayes M; van de Rijn M; Bajdik C; Gilks CB
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6143-51. PubMed ID: 15448001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor.
    Thysell E; Vidman L; Ylitalo EB; Jernberg E; Crnalic S; Iglesias-Gato D; Flores-Morales A; Stattin P; Egevad L; Widmark A; Rydén P; Bergh A; Wikström P
    Mol Oncol; 2019 Aug; 13(8):1763-1777. PubMed ID: 31162796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genes associated with ovarian cancer metastasis using microarray expression analysis.
    Lancaster JM; Dressman HK; Clarke JP; Sayer RA; Martino MA; Cragun JM; Henriott AH; Gray J; Sutphen R; Elahi A; Whitaker RS; West M; Marks JR; Nevins JR; Berchuck A
    Int J Gynecol Cancer; 2006; 16(5):1733-45. PubMed ID: 17009964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Gilles L; Burn JL; Colpaert C; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
    Clin Exp Metastasis; 2007; 24(1):13-23. PubMed ID: 17295094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
    Meyniel JP; Cottu PH; Decraene C; Stern MH; Couturier J; Lebigot I; Nicolas A; Weber N; Fourchotte V; Alran S; Rapinat A; Gentien D; Roman-Roman S; Mignot L; Sastre-Garau X
    BMC Cancer; 2010 May; 10():222. PubMed ID: 20492709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
    Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression signature with independent prognostic significance in epithelial ovarian cancer.
    Spentzos D; Levine DA; Ramoni MF; Joseph M; Gu X; Boyd J; Libermann TA; Cannistra SA
    J Clin Oncol; 2004 Dec; 22(23):4700-10. PubMed ID: 15505275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung.
    Talbot SG; Estilo C; Maghami E; Sarkaria IS; Pham DK; O-charoenrat P; Socci ND; Ngai I; Carlson D; Ghossein R; Viale A; Park BJ; Rusch VW; Singh B
    Cancer Res; 2005 Apr; 65(8):3063-71. PubMed ID: 15833835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.